Most Recent

image: Addressing Biomedical Science’s PhD Problem

Addressing Biomedical Science’s PhD Problem

By | January 1, 2017

Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.

7 Comments

image: Follow the Funding

Follow the Funding

By | May 1, 2015

In times of budget belt-tightening at the federal level, life-science researchers can keep their work supported through private sources.  

9 Comments

image: Let's Make a Deal

Let's Make a Deal

By | February 1, 2013

Six myths about job and salary negotiations and how they may hinder your ability to bargain effectively.

2 Comments

image: In Times of Trouble

In Times of Trouble

By | August 1, 2012

Scientists share their experiences weathering extremely stressful events without letting their careers get completely derailed.

3 Comments

Scientists who pursue advanced degrees are typically smart. They are driven. And they are no doubt passionate about their work. But can they cut it in industry?

1 Comment

image: The Best of Both Worlds

The Best of Both Worlds

By | April 1, 2012

Choosing to work in industry does not preclude a return to academe. But the move back takes some planning and finesse.

3 Comments

Female Frontrunners

By | February 1, 2012

How to successfully surmount the challenges women face in becoming biotech industry leaders

7 Comments

image: Going Governmental

Going Governmental

By | December 1, 2011

Federal agencies offer interesting opportunities for researchers looking to do more than bench work.

12 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham